Pandion Therapeutics, Inc.
SEC CIK 1807901 · PAND · last insider filing 2021-04-01
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Crane Alan L | Director | filed 2020 - 2021 |
| Fuglesang Christopher | Director | filed 2020 - 2021 |
| Carroll Jill | Director | filed 2020 - 2021 |
| Dorton Katina | Director | filed 2020 - 2021 |
| Becker Daniel J. | Director | filed 2020 - 2021 |
| Carlo Rizzuto | Director | filed 2020 - 2021 |
| Kakkar Rahul | Director · Chief Executive Officer | filed 2020 - 2021 |
| Stagliano Nancy | Director | filed 2020 - 2021 |
| Frail Donald | Director | filed 2020 - 2021 |
| Mutz Mitchell | Director | filed 2020 - 2020 |
| GSK plc | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Beloff Gregg | See Remarks | filed 2020 - 2021 |
| Larson Eric D | Vice President, Finance | filed 2020 - 2021 |
| Goyal Vikas | See Remarks | filed 2020 - 2021 |
| Viney Joanne L. | See Remarks | filed 2020 - 2021 |
| Sundy John | Chief Medical Officer | filed 2020 - 2021 |
| Freedman Edward D. | Chief Operating Officer | filed 2020 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.